Tower Research Capital (TRC)’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,478
Closed -$1K 6555
2023
Q1
$1K Buy
+2,478
New +$1K ﹤0.01% 5725
2022
Q2
Sell
-1,092
Closed -$8K 6832
2022
Q1
$8K Buy
1,092
+284
+35% +$2.08K ﹤0.01% 4649
2021
Q4
$5K Buy
808
+117
+17% +$724 ﹤0.01% 5240
2021
Q3
$8K Sell
691
-1,388
-67% -$16.1K ﹤0.01% 4594
2021
Q2
$39K Buy
2,079
+2,019
+3,365% +$37.9K ﹤0.01% 3249
2021
Q1
$1K Buy
+60
New +$1K ﹤0.01% 5253
2017
Q4
Sell
-9
Closed -$4K 4283
2017
Q3
$4K Sell
9
-20
-69% -$8.89K ﹤0.01% 3428
2017
Q2
$17K Buy
+29
New +$17K ﹤0.01% 1324
2016
Q2
Sell
-4
Closed -$2K 5158
2016
Q1
$2K Buy
4
+3
+300% +$1.5K ﹤0.01% 3490
2015
Q4
$1K Sell
1
-1
-50% -$1K ﹤0.01% 4212
2015
Q3
$3K Buy
+2
New +$3K ﹤0.01% 3198
2015
Q2
Sell
-2
Closed -$2K 5246
2015
Q1
$2K Buy
+2
New +$2K ﹤0.01% 3863
2014
Q4
Sell
-18
Closed -$24K 4894
2014
Q3
$24K Buy
18
+12
+200% +$16K ﹤0.01% 2167
2014
Q2
$9K Buy
6
+3
+100% +$4.5K ﹤0.01% 2467
2014
Q1
$6K Sell
3
-2
-40% -$4K ﹤0.01% 3148
2013
Q4
$11K Buy
+5
New +$11K ﹤0.01% 2928